Inspirion Wealth Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-25,000
Closed -$5.28K 170
2024
Q4
$5.28K Hold
25,000
﹤0.01% 155
2024
Q3
$5.79K Buy
25,000
+10,000
+67% +$3.67K ﹤0.01% 156
2024
Q2
$8.16K Hold
15,000
﹤0.01% 149
2024
Q1
$15.3K Buy
15,000
+5,000
+50% +$3.65K ﹤0.01% 148
2023
Q4
$5.86K Buy
+10,000
New +$6.14K ﹤0.01% 138

Other funds holding VIRX

Inspirion Wealth Advisors's VIRX Position: Q1 2025 in Review

Inspirion Wealth Advisors sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q1 2025, closing a stake of 25,000 shares — an estimated $5.28K sold.

Inspirion Wealth Advisors first reported a position in VIRX in Q4 2023 and held it in 5 quarters. The position peaked at $15.3K in Q1 2024. 7 funds tracked by Wall St. Rank hold VIRX as of Q1 2025.

  • Inspirion Wealth Advisors reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Inspirion Wealth Advisors sold 25,000 Viracta Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $5.28K.
  • Inspirion Wealth Advisors first reported a position in Viracta Therapeutics, Inc. Common Stock in Q4 2023 and held it in 5 quarters.
  • Inspirion Wealth Advisors's Viracta Therapeutics, Inc. Common Stock position peaked at $15.3K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Inspirion Wealth Advisors's 13F filing for Q1 2025, filed 9 Apr 2025.